Corporates
MetaSMiteMetaSmite is a Kraków-based biotechnology startup dedicated to developing novel therapeutic solutions targeting metastatic cancer cells. The company focuses on a highly specific and innovative approach involving the plasma membrane citrate transporter (pmCiC), a cancer-specific transporter that plays a crucial role in tumor metabolism and adaptive capabilities. This unique mechanism positions MetaSmite at the forefront of precision medicine in oncology.
The company's mission is to address the critical challenge of cancer metastasis by creating targeted therapies that exploit the unique metabolic dependencies of cancer cells. By inhibiting pmCiC, MetaSmite aims to disrupt the metabolic pathways that enable tumor growth and metastasis, providing a foundation for more effective and personalized cancer treatments.
The company's mission is to address the critical challenge of cancer metastasis by creating targeted therapies that exploit the unique metabolic dependencies of cancer cells. By inhibiting pmCiC, MetaSmite aims to disrupt the metabolic pathways that enable tumor growth and metastasis, providing a foundation for more effective and personalized cancer treatments.
Address
Bożego Miłosierdzia 4, 31-104 Kraków, Poland
Life Science Landscape
Bio-Tech
Pharmaceuticals